NCT06948760View on ClinicalTrials.gov

Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 23, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Type 1 Diabetes
Interventions
DEVICE

Control-IQ insulin pump with Lyumjev insulin

Control-IQ insulin pump with insulin using settings determined by experimental conversion factor

DEVICE

Control-IQ insulin pump with Humalog or Novolog

Control-IQ insulin pump with Humalog or Novolog using optimized insulin settings

Trial Locations (1)

22903

RECRUITING

University of Virginia Center for Diabetes Technology, Charlottesville

All Listed Sponsors
collaborator

University of Virginia

OTHER

lead

Mark D. DeBoer, MD, MSc., MCR

OTHER